Dutasteride and Metformin Reduce the Growth of LNCaP Cells and Alter the SREBP-1 Pathway

The Open Prostate Cancer Journal
doi 10.2174/1876822901306010010
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Bentham Science Publishers Ltd.

Related search

Silibinin Protects Β Cells From Glucotoxicity Through Regulation of the Insig-1/SREBP-1c Pathway

International Journal of Molecular Medicine
MedicineGenetics
2014English

Dihydrotestosterone Induces SREBP-1 Expression and Lipogenesis Through the Phosphoinositide 3-Kinase/Akt Pathway in HaCaT Cells

Lipids in Health and Disease
BiochemistryEndocrinologyClinical BiochemistryMetabolismDiabetes
2012English

SREBP-2, a New Target of Metformin?

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2018English

Chimeric Molecules Facilitate the Degradation of Androgen Receptors and Repress the Growth of LNCaP Cells

Asian Journal of Andrology
MedicineUrology
2008English

Decreased C-Abl Activity in PC-3 and LNCaP Prostate Cancer Cells Overexpressing the Early Growth Response-1 Protein

Oncology Reports
MedicineCancer ResearchOncology
2013English

Role of the AMPK/SREBP-1 Pathway in the Development of Orotic Acid-Induced Fatty Liver

Journal of Lipid Research
BiochemistryEndocrinologyCell Biology
2011English

Metformin Inhibits Growth of Human Glioblastoma Cells and Enhances Therapeutic Response

PLoS ONE
Multidisciplinary
2015English

Human Prostate Fibroblasts Induce Growth and Confer Castration Resistance and Metastatic Potential in LNCaP Cells

European Urology
Urology
2010English

Picropodophyllin Inhibits the Growth of Ewing's Sarcoma Cells Through the Insulin-Like Growth Factor-1 Receptor/Akt Signaling Pathway

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy